Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
01/2004
01/15/2004CA2492690A1 Polymeric charge transport compositions and electronic devices made with such compositions
01/15/2004CA2492689A1 Electronic devices made with electron transport and/or anti-quenching layers
01/15/2004CA2492688A1 Charge transport compositions comprising fluorinated phenanthroline derivatives
01/15/2004CA2492686A1 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices
01/15/2004CA2492121A1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
01/15/2004CA2491998A1 Azabicyclo derivatives as muscarinic receptor antagonists
01/15/2004CA2491994A1 Modulators of the glucocorticoid receptor
01/15/2004CA2491635A1 Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl)-amine derivatives
01/15/2004CA2489251A1 Quinazoline derivatives
01/15/2004CA2489166A1 Substituted anthranilic amide derivatives and methods of use
01/14/2004EP1380583A2 Bis-resorcinol-triazines and their use as sunscreen agents
01/14/2004EP1379566A2 Ion-sensitive cationic polymers and fibrous items using same
01/14/2004EP1379529A2 Pyranocoumarin compounds as a novel pharmacophore with anti-tb activity
01/14/2004EP1379527A1 Epindolidione pigments
01/14/2004EP1379523A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
01/14/2004EP1379522A1 DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I
01/14/2004EP1379521A1 Delta1-pyrrolines
01/14/2004EP1379520A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
01/14/2004EP1379519A1 Pyrrolidine sulfonamides
01/14/2004EP1379514A2 5-membered heterocycles, preparation and application thereof as medicaments
01/14/2004EP1379511A1 DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II
01/14/2004EP1379510A1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers
01/14/2004EP1379501A1 Indolinones, substituted in position 6, and their use as kinase inhibitors
01/14/2004EP1379249A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
01/14/2004EP1379246A1 Nociceptin analogs
01/14/2004EP1379239A2 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
01/14/2004EP1379237A2 Pyrrolidine sulfonamides
01/14/2004CN1468241A Heterocyclic compounds as ligands of the gabaa receptor
01/14/2004CN1468233A Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
01/14/2004CN1468232A Heterocyclic sodium/proton exchange inhibitors and method
01/14/2004CN1468231A Amorphous form of cell cycle inhibitor
01/14/2004CN1468225A 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
01/14/2004CN1468217A Aliphatic nitrogenous five-membered ring compounds
01/14/2004CN1468216A Nitrogenous five-membered ring compounds
01/14/2004CN1468110A Combinations of statins, estrogenic agents and optionally estrogens
01/14/2004CN1134421C Antifungal and its preparation method and intermediate
01/14/2004CN1134420C Novel substituted imidazole compounds
01/14/2004CN1134418C Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation
01/14/2004CN1134414C Substituted oximes, hydrazones and olefins as neurokinin antagonists
01/14/2004CN1134412C N-substituted 2-cyanopyrodlidines
01/14/2004CN1134264C Antithrombotic agents
01/13/2004US6677487 Combining a tertiary amide with a pentavalent phosphorous halide in a solvent to form an alpha - haloiminium salt and converting the alpha -haloiminium salt to the alpha -haloenamine with a base
01/13/2004US6677368 4-aryl substituted indolinones
01/13/2004US6677340 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
01/13/2004US6677337 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
01/13/2004US6677333 2H-phthalazin-1-one derivatives and drug containing its derivatives as active ingredient
01/13/2004US6677110 Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound
01/13/2004US6676909 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching
01/13/2004CA2139731C 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
01/08/2004WO2004002986A2 Novel benzimidazole derivatives
01/08/2004WO2004002965A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
01/08/2004WO2004002964A1 Diaminopyrimidinecarboxa mide derivative
01/08/2004WO2004002960A1 Substituted quinoline ccr5 receptor antagonists
01/08/2004WO2004002477A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses
01/08/2004WO2003090912A9 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
01/08/2004WO2003087088A3 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them
01/08/2004WO2003084928A8 Alpha, omega-dicarboximide derivatives as useful uro-selective α1α adrenoceptor blockers
01/08/2004WO2003076429A3 Azepane derivatives and their use as atk1 inhibitors
01/08/2004WO2003042234A3 Non-peptide somatostatin receptor ligands
01/08/2004US20040006237 Amorphous and crystalline forms of losartan potassium and process for their preparation
01/08/2004US20040006230 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
01/08/2004US20040006123 Interleukin-4 gene expression inhibitors
01/08/2004US20040006122 Methods of treating skin disorders using thio-oxindole derivatives
01/08/2004US20040006108 Useful as insecticides and acaricides
01/08/2004US20040006104 For therapy and prophylaxis of diseases and conditions associated with undesirable or abnormal inflammatory responses, such as ischemia-reperfusion injury, asthma, arthritis
01/08/2004US20040006101 Quinolinone derivatives
01/08/2004US20040006099 Amidine compounds
01/08/2004US20040006094 For prophylaxis of ischemic cell death, particularly neuronal cell death, and reduce the likelihood of neuronal cell death in a subject due to a traumatic event
01/08/2004US20040006090 Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
01/08/2004US20040006088 Substituted N-(indole-2-carbonyl) -amides and derivatives as glycogen phosphorylase inhibitors
01/08/2004US20040006086 For therapy of metabolic and eating disorders such as obesity and hyperphagia, diabetes
01/08/2004US20040006078 For therapy of autoimmune diseases, asthma, osteoporosis, atherosclerosis, Alzheimer's disease
01/08/2004US20040006069 For therapy inflammatory and immune system disorders such as stroke, myocardial infarction, atherosclerosis, ischemic heart disease, ischemia-reperfusion injury
01/08/2004US20040006068 Pyrimidine derivatives
01/08/2004US20040006057 For therapy of connective tissue disorders, inflammatory disorders, immunology/allergy disorders, infectious diseases, respiratory diseases, cardiovascular diseases, eye diseases, metabolic diseases, central nervous system (CNS) disorders
01/08/2004US20040006054 Cytotoxic N-unsubstituted indoles and cyclopent(b)indoles and method of making and using same
01/08/2004US20040005986 Pyridazin-3-one derivatives, their use, and intermediates for their production
01/08/2004DE10227506A1 Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Ring-substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use
01/08/2004CA2491271A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses
01/08/2004CA2489560A1 Substituted quinoline ccr5 receptor antagonists
01/07/2004EP1378230A1 Para-phenylenediamine derivatives comprising a pyrrolidinyl group substituted by a cyclic radical and their use in colouring keratinic fibres
01/07/2004EP1377976A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
01/07/2004EP1377557A1 Methods of synthesizing heteroatom-bearing ligands and intermediate used therefor
01/07/2004EP1377556A1 Pyrazole derivatives for treating hiv
01/07/2004EP1377549A1 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
01/07/2004EP1377278A1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
01/07/2004EP1377264A1 Dyeing composition for dyeing keratinous fibres comprising a cationic azo-dye
01/07/2004EP1377261A1 Dyeing composition for dyeing keratinous fibres comprising a cationic azo-dye
01/07/2004EP1175417B1 Substituted benzolactam compounds
01/07/2004EP1103243B1 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives for the treatment of troubles mediated by an excess of substance p
01/07/2004EP1056733B1 Histamine h3 receptor ligands
01/07/2004EP0748315B1 Use of imidazole derivatives for treating disorders involving angiotensin receptors at1 and at2, these products, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing same
01/07/2004CN1466582A Substituted aryl ketones and their use as herbicides
01/07/2004CN1466572A 吡咯衍生物 Azole derivatives
01/07/2004CN1133635C Cyanopyrroles as progesterone receptor agonists
01/07/2004CN1133634C Heterocyclic derivatives which inhibit factor Xa
01/07/2004CN1133625C Quinazoline derivatives
01/06/2004US6673937 Analogs of deoxypreussomerin, palmarumycin cpi and related naphthoquinone spiroketals; inhibit thioredoxin-thioredoxin reductase system
01/06/2004US6673923 Pyrazole antimicrobial agents
01/06/2004US6673833 As antitumor agent